Patient-Reported Outcomes in KEYNOTE-564: Adjuvant Pembrolizumab Versus Placebo for Renal Cell Carcinoma.

Toni K ChoueiriPiotr TomczakSe Hoon ParkBalaji VenugopalStefan SymeonidesJaroslav HajekThomas FergusonYen-Hwa ChangJae Lyun LeeNaomi HaasPiotr SawryckiNaveed SarwarMarine Gross-GoupilAntoine Thiery-VuilleminMauricio MahaveGo KimuraRodolfo F PeriniTodd L SaretskyRituparna BhattacharyaLei XuThomas Powles

Published in: The oncologist (2023)

Clinicaltrials.gov Identifier: NCT03142334.

Keyphrases

patient reported outcomes
renal cell carcinoma
early stage
advanced non small cell lung cancer
phase ii
double blind
phase iii
clinical trial
placebo controlled
study protocol